Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Sonja %C5%A0kornik) .

41 - 50 / 104
Na začetekNa prejšnjo stran12345678910Na naslednjo stranNa konec
41.
42.
Državni program za obvladovanje raka in njegova vloga v preventivi
Sonja Tomšič, Branko Zakotnik, 2020, objavljeni strokovni prispevek na konferenci

Ključne besede: obvladovanje raka, covid-19, javno zdravje
Objavljeno v DiRROS: 07.04.2021; Ogledov: 1081; Prenosov: 345
.pdf Celotno besedilo (102,42 KB)

43.
Vpliv epidemije covid-19 na diagnostiko in zdravljenje raka
Vesna Zadnik, Ana Mihor, Sonja Tomšič, Tina Žagar, Nika Bric, Katarina Lokar, 2020, objavljeni strokovni prispevek na konferenci

Ključne besede: obvladovanje raka, covid-19, javno zdravje
Objavljeno v DiRROS: 07.04.2021; Ogledov: 1426; Prenosov: 371
.pdf Celotno besedilo (148,08 KB)

44.
CRP projekt : vpliv epidemije covid-19 na obvladovanje raka v Sloveniji
Tina Žagar, Sonja Tomšič, Mario Fafangel, Mateja Krajc, Ana Mihor, Vesna Zadnik, 2020, objavljeni strokovni prispevek na konferenci

Ključne besede: obvladovanje raka, covid-19, javno zdravje
Objavljeno v DiRROS: 07.04.2021; Ogledov: 1139; Prenosov: 334
.pdf Celotno besedilo (99,24 KB)

45.
46.
Znanstveno objavljanje raziskovalnih podatkov v odprti znanosti
Sonja Bezjak, 2021, pregledni znanstveni članek

Ključne besede: podatkovna objava, podatkovni članek, citiranje podatkov, podatkovne storitve
Objavljeno v DiRROS: 07.04.2021; Ogledov: 1571; Prenosov: 492
.pdf Celotno besedilo (791,64 KB)

47.
48.
49.
70 let Registra raka Republike Slovenije : znanje, kakovost, uporabnost
Amela Duratović Konjević, Vesna Škrbec, Sonja Tomšič, Katarina Lokar, Nika Bric, Vesna Zadnik, 2020, strokovna monografija

Ključne besede: onkologija, rak (medicina), registri, zgodovinski pregledi
Objavljeno v DiRROS: 16.03.2021; Ogledov: 1326; Prenosov: 606
.pdf Celotno besedilo (6,47 MB)
Gradivo ima več datotek! Več...

50.
Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in slovenia : a cohort study
Žiga Rotar, Petra Svetina, Matija Tomšič, Alojzija Hočevar, Sonja Praprotnik, 2020, izvirni znanstveni članek

Povzetek: Objectives: This study aimed to assess the risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) treated with any of the commercially available tumour necrosis factor inhibitors (TNFis) in Slovenia. Design: This is a cohort, registry (biorx.si) cross-linked with the Slovenian National TB Registry. Setting: National, involving all Slovenian rheumatology centres (six secondary and two secondary/tertiary). Participants: 2429 patients with RA, AS or PsA exposed to at least one TNFi participated in the study. Primary and secondary outcome measures: The primary outcome measures were age-adjusted and sex-adjusted TB incidence rates (IRs) and the standardised incidence ratios (SIRs) compared with the general population exploring different TNFi exposure windows. The secondary outcome measures were a detailed characterisation of the national latent tuberculosis infection (LTBI) screening and TB chemoprophylaxis protocol implementation. Results: Among the 2429 patients exposed to at least one TNFi for a total of 10 445 (49% RA, 33% AS and 18% PsA) person-years (PY), 99% completed LTBI screening and 6% required TB chemoprophylaxis. Six RA (three adalimumab, three certolizumab), two PsA (two golimumab) and zero AS patients developed TB. Five out of eight had miliary TB, three out of eight had pulmonary TB and two patients died. The age-standardised and sex-standardised TB IR (95% CI) per 100 000 PYs/SIRs (95% CI) compared with the general Slovenian population for the current TNFi exposure were 52 (0 to 110)/6.7 (0.6 to 80), 47 (0 to 110)/6.1 (0.3 to 105), 45 (0 to 109)/5.8 (0.3 to 112) overall, in RA and PsA, respectively. Conclusions: The TB IR in the Slovenian patients with RA, AS and PsA treated with TNFi was comparable with TB IRs in TB non-endemic countries with less than a tenth of the patients requiring TB chemoprophylaxis.
Ključne besede: epidemiology, rheumatology, tuberculosis
Objavljeno v DiRROS: 12.11.2020; Ogledov: 1239; Prenosov: 591
.pdf Celotno besedilo (445,46 KB)

Iskanje izvedeno v 0.35 sek.
Na vrh